文献速递哮喘

成人哮喘患者呼气挥发性有机物与炎症标志物:ALLIANCE队列阴性结果

Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort.
PubMed 文献 · Eur Respir J · 2021-02-11

该信基于ALLIANCE成人哮喘队列,涵盖广泛临床表型,报告呼气挥发性有机物(VOCs)与炎症标志物的关联结果为阴性。作者指出,尽管既往研究反复观察到呼气VOCs与痰或血炎症细胞的关联,但方法学问题未解决且高质量数据缺乏,目前尚无法找到有临床价值的哮喘呼气VOC生物标志物。

要点

  • ALLIANCE成人哮喘队列未发现呼气VOCs与炎症标志物的有意义关联。
  • 呼气组学在哮喘中方法学问题未解决,高质量数据缺乏。
  • 目前尚无可用于哮喘或其表型的临床价值呼气VOC生物标志物。

核心结论

  • 基于ALLIANCE成人哮喘队列的数据,呼气VOCs与炎症标志物的关联结果为阴性。
  • 目前尚无法找到有临床价值的哮喘或哮喘表型呼气VOC生物标志物。

研究设计与样本

  • 研究基于ALLIANCE成人哮喘患者队列,涵盖广泛临床表型,以信件形式报告结果。

主要发现

  • 该队列中呼气VOCs与炎症标志物的关联结果为阴性。
  • 既往研究曾反复观察到呼气VOCs与痰或血炎症细胞的关联,但本队列未重复出有临床价值的发现。

临床怎么用

  • 目前不应将呼气VOC检测作为哮喘或哮喘表型的临床生物标志物工具。

局限性

  • 作者指出呼气组学领域存在未解决的方法学问题和高质量数据普遍缺乏的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite recent publications, we are not close to finding a clinically valuable breath VOC biomarker for asthma or asthma phenotypes https://bit.ly/3heTgtK “Breathomics” in asthma is a rapidly growing area of significant scientific interest, as indicated by a recently published review, two research articles, and their accompanying editorials in high impact pneumology journals [1–5]. The repeatedly observed associations between breath volatile organic compounds (VOCs) and sputum or blood inflammatory cells [2, 3] suggest that breathomics are on the brink of introduction as a valuable clinically tool. However, there are also major concerns about unresolved methodological issues and a general paucity of high-quality data [1, 6]. In this letter we detail our concerns with breathomics based on data from a cohort of adult asthma patients with a broad spectrum of clinical phenotypes.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Holz O, Waschki B, Watz H, et al. Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort. Eur Respir J. 2021. PMID: 33008938. doi:10.1183/13993003.02127-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。